• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

What’s going on at Ophthalmics

Great! Those of us at RVL are not happy with that news!!! We don't want Sun managers and reps coming over here! The best of Sun is the worst from anywhere else! we did not ask for this!

WTF. RVL? Who the F are they? They are trying to sell an allergy drop that is already a 40 year old OTC med. just what the ophthalmologist needs, another allergy med. big woop.